Connection

Denis Guttridge to Cachexia

Back to Details
This is a "connection" page, showing publications Denis Guttridge has written about Cachexia.
Denis Guttridge
Connection Strength
8.001
Cachexia
  1. Cancer cachexia: involvement of an expanding macroenvironment. Cancer Cell. 2023 03 13; 41(3):581-584.
    View in: PubMed
    Score: 0.824
  2. Emerging signaling mediators in the anorexia-cachexia syndrome of cancer. Trends Cancer. 2022 05; 8(5):397-403.
    View in: PubMed
    Score: 0.767
  3. Modeling Human Cancer-induced Cachexia. Cell Rep. 2019 08 06; 28(6):1612-1622.e4.
    View in: PubMed
    Score: 0.643
  4. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-na?ve pancreatic cancer patients. J Cachexia Sarcopenia Muscle. 2018 04; 9(2):358-368.
    View in: PubMed
    Score: 0.576
  5. A TGF-? pathway associated with cancer cachexia. Nat Med. 2015 Nov; 21(11):1248-9.
    View in: PubMed
    Score: 0.495
  6. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia. Semin Cell Dev Biol. 2016 06; 54:82-91.
    View in: PubMed
    Score: 0.491
  7. Inflammation based regulation of cancer cachexia. Biomed Res Int. 2014; 2014:168407.
    View in: PubMed
    Score: 0.447
  8. NF-?B-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest. 2013 Nov; 123(11):4821-35.
    View in: PubMed
    Score: 0.431
  9. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012 Aug 08; 16(2):153-66.
    View in: PubMed
    Score: 0.394
  10. Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome. Clin Cancer Res. 2007 Mar 01; 13(5):1356-61.
    View in: PubMed
    Score: 0.272
  11. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 2005 Nov; 8(5):421-32.
    View in: PubMed
    Score: 0.248
  12. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004 Aug; 114(3):370-8.
    View in: PubMed
    Score: 0.227
  13. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000 Sep 29; 289(5488):2363-6.
    View in: PubMed
    Score: 0.174
  14. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer. Pancreatology. 2019 Jan; 19(1):80-87.
    View in: PubMed
    Score: 0.153
  15. The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia. Cancer Res. 2018 12 01; 78(23):6680-6690.
    View in: PubMed
    Score: 0.151
  16. Cancer-associated cachexia. Nat Rev Dis Primers. 2018 01 18; 4:17105.
    View in: PubMed
    Score: 0.144
  17. Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions. Pancreas. 2017 10; 46(9):1152-1157.
    View in: PubMed
    Score: 0.141
  18. Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities. Mol Cancer Ther. 2017 02; 16(2):344-356.
    View in: PubMed
    Score: 0.133
  19. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia. J Natl Cancer Inst. 2015 Dec; 107(12):djv274.
    View in: PubMed
    Score: 0.123
  20. Cancer cachexia update in head and neck cancer: Pathophysiology and treatment. Head Neck. 2015 Jul; 37(7):1057-72.
    View in: PubMed
    Score: 0.119
  21. Cancer cachexia update in head and neck cancer: Definitions and diagnostic features. Head Neck. 2015 Apr; 37(4):594-604.
    View in: PubMed
    Score: 0.111
  22. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A. 2014 Mar 25; 111(12):4525-9.
    View in: PubMed
    Score: 0.110
  23. Reining in nuclear factor-kappaB in skeletal muscle disorders. Curr Opin Clin Nutr Metab Care. 2013 May; 16(3):251-7.
    View in: PubMed
    Score: 0.104
  24. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One. 2011; 6(7):e22538.
    View in: PubMed
    Score: 0.092
  25. Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine. Int J Oncol. 2010 Apr; 36(4):973-82.
    View in: PubMed
    Score: 0.084
  26. Cachexia: a new definition. Clin Nutr. 2008 Dec; 27(6):793-9.
    View in: PubMed
    Score: 0.075
  27. Immunocompetent murine model of cancer cachexia for head and neck squamous cell carcinoma. Head Neck. 2008 Mar; 30(3):320-6.
    View in: PubMed
    Score: 0.073
  28. Comparison of animal models for head and neck cancer cachexia. Laryngoscope. 2007 Dec; 117(12):2152-8.
    View in: PubMed
    Score: 0.072
  29. The effect of altered Toll-like receptor 4 signaling on cancer cachexia. Arch Otolaryngol Head Neck Surg. 2007 Dec; 133(12):1263-9.
    View in: PubMed
    Score: 0.072
  30. Cancer cachexia syndrome in head and neck cancer patients: Part II. Pathophysiology. Head Neck. 2007 May; 29(5):497-507.
    View in: PubMed
    Score: 0.069
  31. Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck. 2007 Apr; 29(4):401-11.
    View in: PubMed
    Score: 0.068
  32. Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem. 2003 Jan 24; 278(4):2294-303.
    View in: PubMed
    Score: 0.050
  33. Editorial: Highlights from the 2020 virtual cancer cachexia conference. Curr Opin Support Palliat Care. 2021 03 01; 15(1):48-49.
    View in: PubMed
    Score: 0.045
  34. Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer. 2011; 63(5):749-62.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.